a public good project by the
Synthesis
Company
of California

© 2026

Patrizia Nanni | doi.page

0 works0 citations0 h-index

Patrizia Nanni

University of Bologna(IT)

Publications by Year

Research Areas

Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research, Sarcoma Diagnosis and Treatment, HER2/EGFR in Cancer Research

Most-Cited Works

→ 2011: the immune hallmarks of cancer(2011)414 cited
→ DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice(2000)356 cited
→ Vaccines for tumour prevention(2006)340 cited
→ Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice(1998)301 cited
→ Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice(2001)232 cited
→ TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma(1983)224 cited
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

(1998)

Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.(1994)

Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.(2001)

→ Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma(2007)133 cited